Clorox: Hold Near Peak Value as Staples Stalwart Faces Premium
By stockpickr AI | March 1, 2026 | 10 min read
Investment Summary
The Clorox Company appears moderately overvalued based on DCF analysis, although its strong competitive position in the defensive Consumer Staples sector provides stability.
Investment Recommendation
Hold
Fair Value: $128.50
Current Price: $135.34
Upside/Downside: -5.05%
The DCF analysis calculates an implied fair value slightly below the current market price, suggesting the stock is presently trading near its intrinsic worth based on modest growth assumptions. The primary driver is stable, low-single-digit growth consistent with the mature Consumer Staples sector.
Key Metrics
- Market Cap: $21.77B
- P/E Ratio: 32.31x
- Forward P/E: 17.74x
- Revenue Growth (YoY): -2.5%
- Net Margin: 10.01%
- ROE: 49.60%
- Debt/Equity: 1.69
- Dividend Yield: 3.19%
Strengths
- Strong Brand Recognition: Clorox holds leading market shares in iconic segments like household cleaning and disinfecting wipes.
- Stable Cash Generation: As a Consumer Staples firm, CPB exhibits highly predictable and consistent free cash flow generation.
- High Return on Equity: The trailing twelve months ROE stands at approximately 49.6%, indicating highly efficient use of shareholder capital.
- Defensive Profile: The business is inherently resilient to broad economic cycles due to the essential nature of most products.
Risk Factors
- Input Cost Volatility: Recent inflation in raw materials and logistics has pressured gross margins, which could continue.
- Volume Normalization: Post-pandemic sales volumes for certain key disinfectants have normalized, requiring future growth from new product adoption.
- High Leverage: The Debt-to-Equity ratio of 1.69 indicates a relatively high debt load compared to peers, increasing financial risk.
- Competition: Intense competition from private label brands and agile CPG competitors challenges pricing power.